Upload Avatar (500 x 500)
Han Shujun
Life Science
Xi'an Jiaotong University
Shaanxi
Language: Chinese, English
Cancer
Signaling
Therapy
Resistance
Molecular
Mechanisms
Targeted
Drug
Transduction
Tumor
Areas of Focus
- Tumor signal transduction
- Targeted therapy
- Molecular mechanisms of drug resistance
Work Experience
- 2019-present: Associate Professor, Xi'an Jiaotong University, School of Life Sciences and Technology
Academic Background & Achievements
- 2009-2013 Bachelor: Northwest A&F University, College of Animal Science and Technology
- 2013-2019 PhD: Xi'an Jiaotong University, School of Life Sciences and Technology
- 2017-2018 Joint PhD Training: University of California, Davis, School of Medicine
Publications
- lncRNA SAMMSON mediates adaptive resistance to RAF inhibition in BRAF-mutant melanoma cells, Han Shujun et al., 2021
- CPT1A/2-mediated mitochondrial FAO in breast cancer stem cells as a potential target for breast cancer radiotherapy, Han Shujun et al., 2019
- ERK-mediated phosphorylation regulates SOX10 sumoylation and targets expression in mutant BRAF melanoma, Han Shujun et al., 2018
- SIRT3/SOD2 maintains osteoblast differentiation and bone formation by regulating mitochondrial stress, Han Shujun et al., 2018
- O-GlcNAcase deficiency suppresses skeletal myogenesis and insulin sensitivity in mice through the modulation of mitochondrial homeostasis, Han Shujun et al., 2016
- High-Fat-Diet-Induced Weight Gain Ameliorates Bone Loss without Exacerbating AβPP Processing and Cognition in Female APP/PS1 Mice, Han Shujun et al., 2014
- 抑癌基因MIG-6与肿瘤, 韩戍君等, 2014
Awards
- Xi'an Jiaotong University 'Top Ten Academic Newcomers'
- Xi'an Jiaotong University Young Outstanding Talent
